This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

DSM-Firmenich (RDSM) Stock Overview

Provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. More details

RDSM fundamental analysis
Snowflake Score
Valuation6/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends3/6

RDSM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

DSM-Firmenich AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for DSM-Firmenich
Historical stock prices
Current Share Price€114.05
52 Week High€157.25
52 Week Low€108.30
Beta0.72
1 Month Change-4.32%
3 Month Change-8.17%
1 Year Change-21.59%
3 Year Change-2.23%
5 Year Change28.72%
Change since IPO62.33%

Recent News & Updates

Recent updates

Shareholder Returns

RDSMAT ChemicalsAT Market
7D0%0.2%-0.4%
1Y-21.6%-6.9%14.0%

Return vs Industry: RDSM underperformed the Austrian Chemicals industry which returned -7.2% over the past year.

Return vs Market: RDSM underperformed the Austrian Market which returned -8.5% over the past year.

Price Volatility

Is RDSM's price volatile compared to industry and market?
RDSM volatility
RDSM Average Weekly Movementn/a
Chemicals Industry Average Movement5.1%
Market Average Movement4.2%
10% most volatile stocks in AT Market6.0%
10% least volatile stocks in AT Market2.7%

Stable Share Price: RDSM has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine RDSM's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
190219,973Dimitri de Vreezewww.dsm-firmenich.com

DSM-Firmenich AG, a science-based company, engages in health and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants.

DSM-Firmenich AG Fundamentals Summary

How do DSM-Firmenich's earnings and revenue compare to its market cap?
RDSM fundamental statistics
Market cap€762.73m
Earnings (TTM)€454.00m
Revenue (TTM)€8.39b
1.7x
P/E Ratio
0.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RDSM income statement (TTM)
Revenue€8.39b
Cost of Revenue€5.70b
Gross Profit€2.69b
Other Expenses€2.24b
Earnings€454.00m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

Aug 02, 2023

Earnings per share (EPS)67.80
Gross Margin32.06%
Net Profit Margin5.41%
Debt/Equity Ratio26.6%

How did RDSM perform over the long term?

See historical performance and comparison

Dividends

2.2%
Current Dividend Yield
96%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/05/30 00:33
End of Day Share Price 2023/05/23 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DSM-Firmenich AG is covered by 58 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mutlu GundoganABN AMRO Bank N.V.
Martin SchneeAlphaValue
Jennifer BarkerBarclays